These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15265592)

  • 1. Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy.
    Borghi R; Piccini A; Delacourte A; Strocchi P; Zaccheo D; Tabaton M
    Neurosci Lett; 2004 Aug; 366(1):67-70. PubMed ID: 15265592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease.
    Russ C; Lovestone S; Powell JF
    Mol Psychiatry; 2001 May; 6(3):320-4. PubMed ID: 11326302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain.
    Soutar MP; Kim WY; Williamson R; Peggie M; Hastie CJ; McLauchlan H; Snider WD; Gordon-Weeks PR; Sutherland C
    J Neurochem; 2010 Nov; 115(4):974-83. PubMed ID: 20831597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.
    Lee HC; Tsai JN; Liao PY; Tsai WY; Lin KY; Chuang CC; Sun CK; Chang WC; Tsai HJ
    BMC Dev Biol; 2007 Aug; 7():93. PubMed ID: 17683539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy.
    Gibb GM; de Silva R; Revesz T; Lees AJ; Anderton BH; Hanger DP
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):95-101. PubMed ID: 14969740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
    Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
    J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event.
    Cole A; Frame S; Cohen P
    Biochem J; 2004 Jan; 377(Pt 1):249-55. PubMed ID: 14570592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.
    McManus EJ; Sakamoto K; Armit LJ; Ronaldson L; Shpiro N; Marquez R; Alessi DR
    EMBO J; 2005 Apr; 24(8):1571-83. PubMed ID: 15791206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase-3 and the microtubule-associated protein tau in the rat cerebellum.
    Guerra-Araiza C; Amorim MA; Camacho-Arroyo I; Garcia-Segura LM
    Dev Neurobiol; 2007 Mar; 67(4):510-20. PubMed ID: 17443805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
    Pardo M; Abrial E; Jope RS; Beurel E
    Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glycogen Synthase Kinase 3α and β Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus.
    Cortés-Vieyra R; Silva-García O; Oviedo-Boyso J; Huante-Mendoza A; Bravo-Patiño A; Valdez-Alarcón JJ; Finlay BB; Baizabal-Aguirre VM
    PLoS One; 2015; 10(7):e0132867. PubMed ID: 26200352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.